528 related articles for article (PubMed ID: 21119682)
1. Deubiquitinases in the regulation of NF-κB signaling.
Harhaj EW; Dixit VM
Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
[TBL] [Abstract][Full Text] [Related]
2. CYLD: a tumor suppressor deubiquitinase regulating NF-kappaB activation and diverse biological processes.
Sun SC
Cell Death Differ; 2010 Jan; 17(1):25-34. PubMed ID: 19373246
[TBL] [Abstract][Full Text] [Related]
3. Regulation of NF-κB by deubiquitinases.
Harhaj EW; Dixit VM
Immunol Rev; 2012 Mar; 246(1):107-24. PubMed ID: 22435550
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
5. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation.
Tokunaga F; Nishimasu H; Ishitani R; Goto E; Noguchi T; Mio K; Kamei K; Ma A; Iwai K; Nureki O
EMBO J; 2012 Oct; 31(19):3856-70. PubMed ID: 23032187
[TBL] [Abstract][Full Text] [Related]
6. Expression, biological activities and mechanisms of action of A20 (TNFAIP3).
Verstrepen L; Verhelst K; van Loo G; Carpentier I; Ley SC; Beyaert R
Biochem Pharmacol; 2010 Dec; 80(12):2009-20. PubMed ID: 20599425
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
[TBL] [Abstract][Full Text] [Related]
8. Multifaceted role of the ubiquitin ligase Itch in immune regulation.
Venuprasad K; Zeng M; Baughan SL; Massoumi R
Immunol Cell Biol; 2015; 93(5):452-60. PubMed ID: 25582340
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
[TBL] [Abstract][Full Text] [Related]
10. A20-mediated negative regulation of canonical NF-κB signaling pathway.
Pujari R; Hunte R; Khan WN; Shembade N
Immunol Res; 2013 Dec; 57(1-3):166-71. PubMed ID: 24242761
[TBL] [Abstract][Full Text] [Related]
11. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
12. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
13. CYLD, A20 and OTULIN deubiquitinases in NF-κB signaling and cell death: so similar, yet so different.
Lork M; Verhelst K; Beyaert R
Cell Death Differ; 2017 Jul; 24(7):1172-1183. PubMed ID: 28362430
[TBL] [Abstract][Full Text] [Related]
14. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
15. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN.
Takiuchi T; Nakagawa T; Tamiya H; Fujita H; Sasaki Y; Saeki Y; Takeda H; Sawasaki T; Buchberger A; Kimura T; Iwai K
Genes Cells; 2014 Mar; 19(3):254-72. PubMed ID: 24461064
[TBL] [Abstract][Full Text] [Related]
16. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains.
Düwel M; Welteke V; Oeckinghaus A; Baens M; Kloo B; Ferch U; Darnay BG; Ruland J; Marynen P; Krappmann D
J Immunol; 2009 Jun; 182(12):7718-28. PubMed ID: 19494296
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
18. The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation.
Rodriguez MS; Egaña I; Lopitz-Otsoa F; Aillet F; Lopez-Mato MP; Dorronsoro A; Lobato-Gil S; Sutherland JD; Barrio R; Trigueros C; Lang V
Cell Death Dis; 2014 Aug; 5(8):e1399. PubMed ID: 25165885
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling.
Enesa K; Zakkar M; Chaudhury H; Luong le A; Rawlinson L; Mason JC; Haskard DO; Dean JL; Evans PC
J Biol Chem; 2008 Mar; 283(11):7036-45. PubMed ID: 18178551
[TBL] [Abstract][Full Text] [Related]
20. Regulation of NF-κB signaling by the A20 deubiquitinase.
Shembade N; Harhaj EW
Cell Mol Immunol; 2012 Mar; 9(2):123-30. PubMed ID: 22343828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
